Ionis Pharma (IONS), Akcea Therapeutics (AKCA) Partner on Inotersen for hATTR; $150M Upfront to Ionis Paid in Stock
Tweet Send to a Friend
Ionis Pharmaceuticals (NASDAQ: IONS) and Akcea Therapeutics, Inc. (NASDAQ: AKCA) announced an exclusive, worldwide license by Ionis to Akcea for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
